Back to results
US 11,439,635 B2Granted
B cell lymphoma 6 protein (BCL6) as a target for treating diabetes mellitus and non-alcoholic fatty liver disease
AssigneeNorthwestern University
InventorsGrant D. Barish, Meredith A. Sommars, Madhavi D. Senagolage
Life of this patent
Estimating the term…
Abstract
Disclosed are methods and compositions for treating diabetes mellitus and non-alcoholic fatty liver disease by administering a therapeutic agent that inhibits the biological activity of B cell lymphoma 6 protein (BCL6).
Claims8
A method for treating non-alcoholic fatty liver disease in a subject in need thereof, the method comprising administering to the subject a therapeutic agent that inhibits the expression of B cell lymphoma protein 6 (BCL6).
Dependencies are inferred from the claim text.